CSE: HUGE NASDAQ: HUGE FRA: 0K9A
CSE: HUGE NASDAQ: HUGE FRA: 0K9A

About Us

FSD Pharma is a specialty biotech pharmaceutical company that is advancing the research and development of synthetic compounds that target the endocannabinoid system of the human body.

READ MORE

Our Mission

We are a science driven company focused on the development of FDA approved synthetic compounds that address unmet medical needs.

News

June 3, 2020

FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis

Learn More »
May 21, 2020

FSD Pharma Monetizes Non-Core Asset with Sale of Partial Equity Stake in Pharmadrug Inc.

Learn More »
May 14, 2020

FSD Pharma Reports First Quarter 2020 Financial Results

Learn More »
MORE NEWS & MEDIA